Detalles de la búsqueda
1.
Frequent upregulation of HER2 protein in hormone-receptor-positive HER2-negative breast cancer after short-term neoadjuvant endocrine therapy.
Breast Cancer Res Treat
; 201(3): 387-396, 2023 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-37460683
2.
Matched Case Control Analysis of Breast Cancer- Specific Factors Affecting Risk of Developing SARS-CoV-2 Infection.
WMJ
; 122(5): 418-421, 2023 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-38180937
3.
Frequent Upregulation Of HER2 Protein In Hormone Receptor-Positive HER2-Negative Breast Cancer After Short-Term Neoadjuvant Endocrine Therapy.
Res Sq
; 2023 Apr 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-37066270
4.
Androgen receptor expression in patients with triple negative breast cancer treated with neoadjuvant chemotherapy: a single institution study.
J Cancer
; 13(8): 2472-2476, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35711833
5.
Long-Term Outcomes of Dose-Escalated Pelvic Lymph Node Intensity-Modulated Radiation Therapy (IMRT) With a Simultaneous Hypofractionated Boost to the Prostate for Very High-Risk Adenocarcinoma of the Prostate: A Prospective Phase II Clinical Trial.
Pract Radiat Oncol
; 11(6): 527-533, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-33848618
6.
Immune Check Point Inhibition in Sarcomatoid Renal Cell Carcinoma: A New Treatment Paradigm.
Clin Genitourin Cancer
; 15(5): e897-e901, 2017 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-28645484
Resultados
1 -
6
de 6
1
Próxima >
>>